RIGEL PHARMACEUTICALS INC (RIGL) Stock Balance Sheet
NASDAQ:RIGL • US7665597024
Current stock price
32.43 USD
+0.66 (+2.08%)
At close:
32.43 USD
0 (0%)
After Hours:
| 2025 (2025-12-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 40.58M | 56.75M | 32.79M | 24.50M | 18.90M | |||
| Marketable Securities | 114.38M | 20.57M | 24.15M | 33.70M | 106.10M | |||
| Receivables | 51.76M | 41.62M | 30.55M | 40.30M | 15.50M | |||
| Inventories | 11.51M | 6.00M | 5.52M | 9.10M | 6.60M | |||
| Other Current Assets | 21.94M | 10.16M | 6.26M | 8.30M | 7.40M | |||
| Total Current Assets | 240.17M | 135.10M | 99.27M | 115.90M | 154.50M | |||
| Non-Current Assets | ||||||||
| PPE Net | 950.00K | 338.00K | 1.03M | 2.80M | 11.90M | |||
| Intangibles | 24.75M | 27.10M | 13.88M | 14.90M | N/A | |||
| Other Non-Current Assets | 247.73M | 1.44M | 3.06M | 600.00K | 1.00M | |||
| Total Non-Current Assets | 273.43M | 28.87M | 17.96M | 18.40M | 12.80M | |||
| TOTAL ASSETS | 513.59M | 163.98M | 117.22M | 134.30M | 167.30M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | 29.81M | 7.27M | 7.23M | N/A | N/A | |||
| Accrued Expenses | 28.16M | 24.89M | 18.21M | 24.20M | 43.70M | |||
| Accounts Payable | 7.19M | 3.34M | 7.14M | 22.50M | 3.80M | |||
| Other Current Liabilities | 34.07M | 27.80M | 20.68M | 18.50M | 16.10M | |||
| Total Current Liabilities | 99.24M | 63.30M | 53.27M | 65.20M | 63.60M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 22.48M | 52.41M | 52.37M | 39.40M | 19.90M | |||
| Other Non-Current Liabilities | 395.00K | 44.98M | 40.23M | 43.20M | 53.50M | |||
| Total Non-Current Liabilities | 22.88M | 97.39M | 92.60M | 82.70M | 73.40M | |||
| TOTAL LIABILITIES | 122.11M | 160.69M | 145.87M | 147.90M | 137.00M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -1.02B | -1.39B | -1.41B | -1.38B | -1.32B | |||
| Additional Paid In Capital | 1.41B | 1.39B | 1.38B | 1.37B | 1.35B | |||
| Common Shares | 18.00K | 18.00K | 175.00K | 200.00K | 200.00K | |||
| Other Shareholders' Equity | 181.00K | 10.00K | 8.00K | -200.00K | -100.00K | |||
| Shares Outstanding | 18.31M | 17.71M | 17.48M | 173.40M | 171.60M | |||
| Tangible Book Value per Share | 20.03 | -1.34 | -2.43 | -0.16 | 0.18 | |||
| Total Shareholders' Equity | 391.48M | 3.29M | -28.64M | -13.60M | 30.40M | |||
| TOTAL LIABILITIES AND EQUITY | 513.59M | 163.98M | 117.22M | 134.30M | 167.30M | |||
| Statistics | ||||||||
| Debt/Equity | 0.06 | 15.94 | -1.83 | -2.90 | 0.65 | |||
| Current Ratio | 2.42 | 2.13 | 1.86 | 1.78 | 2.43 | |||
| Return On Assets (ROA) | 71.46% | 10.66% | -21.40% | -43.63% | -10.70% | |||
| Return On Equity (ROE) | 93.75% | 531.78% | N/A | N/A | -58.88% | |||
| Return On Invested Capital (ROIC) | 23.92% | 18.98% | N/A | N/A | N/A | |||
| Return On Invested Capital Ex Cash (ROICexc) | 38.21% | 81.83% | N/A | N/A | N/A | |||
| Return On Invested Capital Ex Cash + Goodwill (ROICexgc) | 42.24% | N/A | N/A | N/A | N/A | |||
All data in USD , ROIC based on taxRate of 0.21